Integrating developmental signals: A Hippo in the (path)way

Oncogene

Volumn 31, Issue 14, 2012, Pages 1743-1756

  Mauviel, A ^a,b,c   Nallet Staub, F ^a,b,c   Varelas, X ^d  

^a INSTITUT CURIE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

growth control; Hippo signaling; TAZ; TGF signaling; Wnt signaling; YAP

Indexed keywords

BETA CATENIN; HIPPO PROTEIN; PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TAZ PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; YAP PROTEIN;

CANCER GROWTH; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

DROSOPHILA PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 84859583470     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.363     Document Type: Review

References (146)

1. Affolter M, Basler K. (2007). The Decapentaplegic morphogen gradient: from pattern formation to growth regulation. Nat Rev Genet 8: 663-674. (Pubitemid 47281990)
2. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S et al. (2009). Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139: 757-769.
3. Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massague J et al. (2011). A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev 25: 1275-1288.
4. Arnold SJ, Robertson EJ. (2009). Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nat Rev Mol Cell Biol 10: 91-103.
5. Attisano L, Labbe E. (2004). TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 23: 53-61.
6. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X et al. (2010). The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 24: 2420-2429.
7. Baena-Lopez LA, Rodriguez I, Baonza A. (2008). The tumor suppressor genes dachsous and fat modulate different signalling pathways by regulating dally and dally-like. Proc Natl Acad Sci USA 105: 9645-9650. (Pubitemid 352031354)
8. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS et al. (2005). High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307: 1621-1625. (Pubitemid 40354744)
9. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11-23. (Pubitemid 36126587)
10. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. (2010). The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 18: 309-316.
11. Bulgakova NA, Knust E. (2009). The Crumbs complex: from epithelial-cell polarity to retinal degeneration. J Cell Sci 122: 2587-2596.
12. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R et al. (2007). YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060. (Pubitemid 350180465)
13. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. (2011a). Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018-7026.
14. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W et al. (2008). A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598. (Pubitemid 351556257)
15. Chan SW, Lim CJ, Huang C, Chong YF, Gunaratne HJ, Hogue KA et al. (2011). WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30: 600-610.
16. Chan SW, Lim CJ, Loo LS, Chong YF, Huang C, Hong W. (2009). TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem 284: 14347-14358.
17. Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD. (2006). Delineation of a Fat tumor suppressor pathway. Nat Genet 38: 1142-1150. (Pubitemid 44470359)
18. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
19. Corbit KC, Shyer AE, Dowdle WE, Gaulden J, Singla V, Chen MH et al. (2008). Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms. Nat Cell Biol 10: 70-76.
20. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I. (2003). Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23: 1004-1013. (Pubitemid 36138760)
21. Dai F, Duan X, Liang YY, Lin X, Feng XH. (2010). Coupling of dephosphorylation and nuclear export of Smads in TGF-beta signaling. Methods Mol Biol 647: 125-137.
22. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. (2003). Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5: 410-421. (Pubitemid 36592263)
23. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D et al. (2009). TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp Cell Res 315: 162-175.
24. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. (2007). Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133. (Pubitemid 47410268)
25. Duning K, Rosenbusch D, Schluter MA, Tian Y, Kunzelmann K, Meyer N et al. (2010). Polycystin-2 activity is controlled by transcriptional coactivator with PDZ binding motif and PALS1-associated tight junction protein. J Biol Chem 285: 33584-33588.
26. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al. (2011). Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183.
27. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T et al. (2001). Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477-12480.
28. Espanel X, Sudol M. (2001). Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem 276: 14514-14523.
29. Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S et al. (2009). YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev 23: 2729-2741.
30. Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A et al. (2002). Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene 21: 4879-4884.
31. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. (2010). Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18: 300-308.
32. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M et al. (1998). Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. Embo J 17: 2224-2234. (Pubitemid 28171908)
33. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE. (2010). Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20: 573-581.
34. Habbig S, Bartram MP, Muller RU, Schwarz R, Andriopoulos N, Chen S et al. (2011). NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J Cell Biol 193: 633-642.
35. Harvey KF, Pfleger CM, Hariharan IK. (2003). The Drosophila Mst ortholog, Hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114: 457-467. (Pubitemid 37100994)
36. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. (1998). Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186-197. (Pubitemid 28060449)
37. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW et al. (1997). The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89: 1165-1173. (Pubitemid 127678749)
38. Heallen T, Zhang M, Wang J, Bonilla-ClaudioM, Klysik E, Johnson RL et al. (2011). Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332: 458-461.
39. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R et al. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309: 1074-1078. (Pubitemid 41134465)
40. Hong JH, Yaffe MB. (2006). TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 5: 176-179.
41. Hori T, Takaori-Kondo A, Kamikubo Y, Uchiyama T. (2000). Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor. Oncogene 19: 3101-3109. (Pubitemid 30438467)
42. Hossain Z, Ali SM, Ko HL, Xu J, Ng CP, Guo K et al. (2007). Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc Natl Acad Sci USA 104: 1631-1636. (Pubitemid 46214642)
43. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M et al. (1997). Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389: 622-626. (Pubitemid 27446182)
44. Islas S, Vega J, Ponce L, Gonzalez-Mariscal L. (2002). Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 274: 138-148.
45. Jang SW, Yang SJ, Srinivasan S, Ye K. (2007). Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. J Biol Chem 282: 30836-30844. (Pubitemid 350035233)
46. Javelaud D, Mauviel A. (2004). Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol 36: 1161-1165. (Pubitemid 38515657)
47. Jia J, Zhang W, Wang B, Trinko R, Jiang J. (2003). The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 17: 2514-2519. (Pubitemid 37271421)
48. Jiang Z, Li X, Hu J, Zhou W, Jiang Y, Li G et al. (2006). Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci Res 56: 450-458. (Pubitemid 44750270)
49. Jimenez-Velasco A, Roman-Gomez J, Agirre X, Barrios M, Navarro G, Vazquez I et al. (2005). Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia 19: 2347-2350. (Pubitemid 41741637)
50. Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. (1995). The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534-546.
51. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M et al. (2000). TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. Embo J 19: 6778-6791. (Pubitemid 32011671)
52. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ et al. (2002). Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129: 5719-5730. (Pubitemid 36054615)
53. Karpowicz P, Perez J, Perrimon N. (2010). The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 137: 4135-4145.
54. Kato Y, Habas R, Katsuyama Y, Naar AM, He X. (2002). A component of the ARC/Mediator complex required for TGFbeta/Nodal signalling. Nature 418: 641-646.
55. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375. (Pubitemid 32045929)
56. Kim D, Shu S, Coppola MD, Kaneko S, Yuan ZQ, Cheng JQ. (2010). Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway. PLoS One 5: e9616.
57. Kimelman D, Xu W. (2006). beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482-7491. (Pubitemid 44885747)
58. Komuro A, Nagai M, Navin NE, Sudol M. (2003). WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278: 33334-33341. (Pubitemid 37055785)
59. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N et al. (2005). Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120: 675-685. (Pubitemid 40343079)
60. Lee KK, Ohyama T, Yajima N, Tsubuki S, Yonehara S. (2001). MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 276: 19276-19285.
61. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. (2008). TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol Cell Biol 28: 2426-2436. (Pubitemid 351429986)
62. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J et al. (2010). The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118.
63. Ling C, Zheng Y, Yin F, Yu J, Huang J, Hong Y et al. (2010). The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci USA 107: 10532-10537.
64. Liu CY, Lv X, Li T, Xu Y, Zhou X, Zhao S et al. (2011). PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J Biol Chem 286: 5558-5566.
65. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D et al. (2010). The Hippo tumor pathway promotes TAZ degradation by phosphory. J Biol Chem 285: 37159-37169.
66. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q et al. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 107: 1437-1442.
67. MacDonald BT, Tamai K, He X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
68. Makita R, Uchijima Y, Nishiyama K, Amano T, Chen Q, Takeuchi T et al. (2008). Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol 294: F542-F553. (Pubitemid 351442224)
69. Massague J, Seoane J, Wotton D. (2005). Smad transcription factors. Genes Dev 19: 2783-2810. (Pubitemid 41739965)
70. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D et al. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962-975. (Pubitemid 47495894)
71. Meignin C, Alvarez-Garcia I, Davis I, Palacios IM. (2007). The Salvador-Warts-Hippo pathway is required for epithelial proliferation and axis specification in Drosophila. Curr Biol 17: 1871-1878. (Pubitemid 350016928)
72. Miller BW, Lau G, Grouios C, Mollica E, Barrios-Rodiles M, Liu Y et al. (2009). Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway. Mol Syst Biol 5: 315.
73. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG et al. (2006). Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 26: 77-87.
74. Murakami M, Nakagawa M, Olson EN, Nakagawa O. (2005). A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 102: 18034-18039. (Pubitemid 41798497)
75. Murakami M, Tominaga J, Makita R, Uchijima Y, Kurihara Y, Nakagawa O et al (2006). Transcriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 339: 533-539. (Pubitemid 41739700)
76. Nicolas FJ, De Bosscher K, Schmierer B, Hill CS. (2004). Analysis of Smad nucleocytoplasmic shuttling in living cells. J Cell Sci 117: 4113-4125. (Pubitemid 39328299)
77. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A et al. (2009). The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 16: 398-410.
78. Nusse R. (2005). Wnt signaling in disease and in development. Cell Res 15: 28-32.
79. Oh H, Irvine KD. (2011). Cooperative regulation of growth by Yorkie and Mad through bantam. Dev Cell 20: 109-122.
80. Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D et al. (2010). Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 432: 461-472.
81. Oka T, Schmitt AP, Sudol M. (2011). Opposing roles of angiomotin like 1 and zona occludens-2 on proapoptotic function of YAP. Oncogene (e-pub ahead of print 20 June 2011; doi:10.1038/onc.2011.216).
82. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al. (2006). Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 103: 12405-12410. (Pubitemid 44267272)
83. Pan D. (2010). The Hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
84. Pantalacci S, Tapon N, Leopold P. (2003). The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5: 921-927. (Pubitemid 37220699)
85. Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, Zannini M. (2004). TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem 279: 17384-17390. (Pubitemid 38560499)
86. Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore Jr JJ, Leof EB. (2002). Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway. Mol Cell Biol 22: 4750-4759. (Pubitemid 34620410)
87. Polesello C, Tapon N. (2007). Salvador-Warts-Hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch. Curr Biol 17: 1864-1870. (Pubitemid 350016921)
88. Reddy BV, Rauskolb C, Irvine KD. (2010). Influence of fat-Hippo and notch signaling on the proliferation and differentiation of Drosophila optic neuroepithelia. Development 137: 2397-2408.
89. Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove J, Sudol M et al. (2010). TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett 584: 4175-4180.
90. Ren F,Wang B, Yue T, Yun EY, Ip YT, Jiang J. (2010). Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci USA 107: 21064-21069.
91. Robinson BS, Huang J, Hong Y, Moberg KH. (2010). Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 20: 582-590.
92. Rotin D. (1998). WW (WWP) domains: from structure to function. Curr Top Microbiol Immunol 228: 115-133.
93. Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A et al. (2001). Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene 20: 5972-5981. (Pubitemid 32955039)
94. Sansom OJ, Griffiths DF, Reed KR, Winton DJ, Clarke AR. (2005). Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 24: 8205-8210. (Pubitemid 41759819)
95. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC et al. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419: 407-411.
96. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D et al. (2011). Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795.
97. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. (2004). Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 6: 73-77. (Pubitemid 38425733)
98. Seidel C, Schagdarsurengin U, Blumke K, Wurl P, Pfeifer GP, Hauptmann S et al. (2007). Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog 46: 865-871. (Pubitemid 47549772)
99. Shaw RL, Kohlmaier A, Polesello C, Veelken C, Edgar BA, Tapon N. (2010). The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 137: 4147-4158.
100. Shi Y, Massague J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
101. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD et al. (2011). \{alpha\}-Catenin is a tumor suppressor that controls cell accumul. Sci Signal 4: ra33.
102. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L et al. (2010). Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 107: 1431-1436.
103. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG et al. (1999). Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21: 182-186. (Pubitemid 29070363)
104. Staley BK, Irvine KD. (2010). Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Curr Biol 20: 1580-1587.
105. Steinmann K, Sandner A, Schagdarsurengin U, Dammann RH. (2009). Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 22: 1519-1526.
106. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al. (2001). Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276: 15164-15173.
107. Sudol M. (1994). Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9: 2145-2152.
108. Sudol M. (2011). Newcomers to the WW domain - mediated network of the Hippo tumor suppressor pathway. Genes Cancer 1: 1115-1118.
109. Sudol M, Bork P, Einbond A, Kastury K, Druck T, Negrini M et al. (1995). Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem 270: 14733-14741.
110. Sudol M, Sliwa K, Russo T. (2001). Functions of WW domains in the nucleus. FEBS Lett 490: 190-195. (Pubitemid 32171938)
111. Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y et al. (2005). Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin Cancer Res 11: 1380-1385. (Pubitemid 40315216)
112. Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W et al. (1999). Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 21: 177-181. (Pubitemid 29070362)
113. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA et al. (2002). Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467-478. (Pubitemid 35232290)
114. Thiery JP, Acloque H, Huang RY, Nieto MA. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
115. Tian Y, Kolb R, Hong JH, Carroll J, Li D, You J et al. (2007). TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol Cell Biol 27: 6383-6395. (Pubitemid 47435745)
116. Tyler DM, Baker NE. (2007). Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways. Dev Biol 305: 187-201. (Pubitemid 46589414)
117. Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. (2003). Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5: 914-920. (Pubitemid 37220698)
118. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J et al. (2008). TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10: 837-848. (Pubitemid 351927712)
119. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA et al. (2010a). The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 18: 579-591.
120. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG et al. (2010b). The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19: 831-844.
121. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. (2001). TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15: 1229-1241. (Pubitemid 32472752)
122. Vigneron AM, Ludwig RL, Vousden KH. (2010). Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev 24: 2430-2439.
123. Wang T. (2003). The 26S proteasome system in the signaling pathways of TGF-beta superfamily. Front Biosci 8: d1109-d1127.
124. Webb C, Upadhyay A, Giuntini F, Eggleston I, Furutani-Seiki M, Ishima R et al. (2011). Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry 50: 3300-3309.
125. Wrana JL. (2000). Regulation of Smad activity. Cell 100: 189-192.
126. Wu S, Huang J, Dong J, Pan D. (2003). Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445-456. (Pubitemid 37100993)
127. Xiao L, Chen Y, Ji M, Dong J. (2011). KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J Biol Chem 286: 7788-7796.
128. Xiao Z, Watson N, Rodriguez C, Lodish HF. (2001). Nucleocytoplasmic shuttling of smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem 276: 39404-39410. (Pubitemid 37371318)
129. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. (1999). A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. Embo J 18: 2551-2562. (Pubitemid 29213286)
130. Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N et al. (2011). A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 19: 527-540.
131. Yim H, Sung CK, You J, Tian Y, Benjamin T. (2011). Nek1 and TAZ interact to maintain normal levels of polycystin 2. J Am Soc Nephrol 22: 832-837.
132. Yu J, Poulton J, Huang YC, Deng WM. (2008). The Hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity. PLoS One 3: e1761.
133. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. (2010). Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 18: 288-299.
134. Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L et al. (2010). Phosphoinositide 3-kinase/Akt inhibits MST1-mediated proapoptotic signaling through phosphorylation of threonine 120. J Biol Chem 285: 3815-3824.
135. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S et al. (2009a). TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 284: 13355-13362.
136. Zhang H, Pasolli HA, Fuchs E. (2011). Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci USA 108: 2270-2275.
137. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R et al. (2009b). YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 11: 1444-1450.
138. Zhang X, Milton CC, Humbert PO, Harvey KF. (2009c). Transcriptional output of the Salvador/Warts/Hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines. Cancer Res 69: 6033-6041.
139. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. (2001). Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 98: 974-979. (Pubitemid 32121172)
140. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761. (Pubitemid 350070721)
141. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971. (Pubitemid 352008643)
142. Zhao B, Kim J, Ye X, Lai ZC, Guan KL. (2009). Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 69: 1089-1098.
143. Zhao B, Li L, Lei Q, Guan KL. (2010a). The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24: 862-874.
144. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
145. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. (2010b). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85.
146. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. (2009). Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425-438.